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Baseline characteristics of 34 ESRD patients on HD.
Clinical characteristics Values
Age (years) 67.3 ± 10.5
Male (%) 67.6
Duration on HD (years) 9.3 ± 8.3
Body weight before HD (kg) 57.0 ± 10.2
BMI before HD (kg/m2) 22.1 ± 2.9
Hypertension (%) 94.1
Diabetes mellitus (%) 52.9
Laboratory data before HD Values
BUN (mg/dL) 51.9 ± 13.9
Creatinine (mg/dL) 10.3 ± 2.9
Sodium (mEq/L) 137 ± 2.8
Potassium (mEq/L) 4.4 ± 0.7
Calcium (mg/dL) 8.7 ± 0.6
Albumin (g/dL) 3.5 ± 0.5
CRP(mg/dL) 0.6 ± 0.9
Hemoglobin(g/dL) 10.3 ± 1.2
Uric acid (mg/dL) 6.6 ± 1.2
LDL-C (mg/dL) 70.7 ± 29.1
HDL-C(mg/dL) 42.6 ± 11.1
Data are expressed as means ± standard deviations.
Abbreviations used: ESRD, end-stage renal disease; HD, hemodialysis; BMI,
body mass index; BUN, blood urea nitrogen; CRP, C-reactive protein; LDL-C,
low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein
cholesterol.Novel vascular indices evaluated non-invasively in end-stage renal
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Blood pressure (BP) is pulse wave caused by cardiac and vascular
functions, and systolic BP (SBP) and diastolic BP (DBP) are just maxi-
mum and minimum values of this pulse wave, respectively. On the
other hand, mean BP (MBP) reﬂects averaged squares which the pulse
wave occupies, and pulse pressure (PP) is the amplitude of pulse wave
and is known to be associated with compliances of elastic artery.
Hence, to measureMBP and PP could bemore valuable than tomeasure
SBP and DBP for evaluating organ damages. Furthermore, increased
central BP (CBP) causes vascular wall stresses in peripheral vessels
and accelerates atherosclerosis in these arteries, leading various cardio-
vascular diseases (CVDs). CBP is also known to be amore precise predic-
tor of CVD than brachial BP measured oscillometrically [1]. PP, deﬁned
as the amplitude of pulse wave, generally reﬂects increased large arteri-
al stiffness [2], and might be a reliable predictor of cardiovascular mor-
tality in both general and hypertensive populations [3]. Recently, we
also reported that PP could be a more useful risk marker in coronary ar-
tery disease (CAD) patients than other BP parameters [4].
Patients with chronic kidney disease (CKD) explosively increased
worldwide, and increasing end-stage renal disease (ESRD) patients on
hemodialysis (HD) have been social problems in recent days [5,6]. Be-
cause the main causes of death in ESRD patients on HD are CVDs [7],
risk stratiﬁcation of CVD in these patients might be very important.
However, hemodynamic status and vascular compliances of HDpatients
are entirely speciﬁc in CKD patients. Therefore, clinical signiﬁcances of
BP and vascular function measurements such as pulse wave velocity
(PWV) or cardio-ankle vascular index (CAVI) in ESRD patients could
be also different from those in non-HD patients.
We recently reported a novel mathematical transformation function
(TF) for CBP values estimated by non-invasive oscillometric BP mea-
surements [8], and the association of estimated CBP with PWV in CAD
patients by using new vascular indices, such as arterial velocity pulse
index (AVI) and arterial pressure-volume index (API) [9]. In the present
study, hence, we sought to examine the association of estimated CBP
and PP with AVI and API in ESRD patients.
We recruited 34 ESRD patients whowere on regular HD three times
a week. Oscillometrical brachial BP in patients was routinely measured
just before HD. CBP, AVI and API values were measured non-invasively
by a Pasesa AVE-1500 (Shisei Datum, Tokyo, Japan) in the opposite
upper arm of arteriovenous shunt side, and were calculated using new
TF in HD patients. In brief, we made a correlation matrix to investigatehttp://dx.doi.org/10.1016/j.ctrsc.2015.09.001
2405-5875/© 2015 The Authors. Published by Elsevier B.V. This is an open access article underthe correlation among several independent variables. The independent
variables, which had signiﬁcant correlations with aortic systolic BP
(AoSBP) were age, SBP, DBP, AVI and API values obtained in this matrix.
To examine multiple regression equation, we used AoSBP as a depen-
dent variable and adopted the ﬁve above-mentioned variables as inde-
pendent variables. We obtained intercepts and coefﬁcients for each
independent variable and constructed the formulas. CAVI values in HD
patients were measured using a device for a VaSera VS-1500 (Fukuda
Denshi Co., Tokyo, Japan), according to the method reported previously
[10].
The baseline characteristics of HD patients were shown in Table 1
(male; n = 24 [71%] and female; n = 10 [29%], average: 67.3 ±
10.5 years old). The causative diseases of HD were diabetic nephropa-
thy(52.9%), chronic glomerulonephritis(14.7%), nephrosclerosis(5.9%)
and others(26.5%). The duration of HD was 9.3 ± 8.3 (years). The esti-
mated CBP was signiﬁcantly and strongly correlated both with AVI
and API values (r = 0.42, p = 0.013 and r = 0.66, p b 0.001, Fig. 1A
and B, respectively), and the brachial PP values were also signiﬁcantly
and strongly correlated with AVI and API values (r = 0.43, p = 0.011
and r = 0.81, p b 0.001 Fig. 1C and D, respectively). By contrast, the
CAVI values were not signiﬁcantly correlated with AVI and API values
(r = 0.04, p = 0.82 and r = 0.14, p = 0.43 Fig. 2A and B, respectively).
As described above, MBP and PP could be more valuable than SBP
and DBP, and CBP is well known to be better predictor of CVD than bra-
chial BP measured oscillometrically. Also brachial PP might bethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A and B, the correlations of estimated central SBP with AVI and API valves. C and D, the correlations of PP with AVI and API values. MBP, mean blood pressure; AVI, arterial velocity
pulse index; API, arterial pressure-volume index; SBP;, systolic blood pressure; PP, pulse pressure.
2 Novel vascular indices evaluated non-invasively in end-stage renal disease patients on hemodialysispredictive factor of CVD in various patients, however the signiﬁcance of
PP in ESRD patients remains still unclear. In this study, hence, we inves-
tigated the association of central MBP and brachial PP with vascular in-
dices in ESRD, using newmodality of BPmeasurement. As a result, there
were signiﬁcant correlations of CBP and PP values with AVI and API
values in these patients.
Because PWV was reported to be associated with the prognosis of
HD patients [11], the assessment of vascular function might be useful
also in HD patients. This study demonstrated that both AVI and API
values, new vascular indices, were strongly associated with MBP and
PP, which are established as prognostic factors of CVD, in HD patients.
These indicated that the AVI and API have possibility to be useful predic-
tors of CVD occurrence in ESRD patients. Although the AVI and API are
very new vascular indices [8,9,12] and there are no reports demonstrat-
ing prognostic signiﬁcance of these indices in CVD. We ﬁrstly clariﬁed
the signiﬁcant association of AVI and API with other BP parameters inFig. 2. A and B; the correlations of CAVI, with AVI and API values. CAVI; carHD patients, and the usefulness of new TF for risk stratiﬁcation of
ESRDpatients. On the other hand, the CAVI valueswere not signiﬁcantly
correlated with AVI and API values in this study. Although CAVI is
established as useful modality estimating vascular function, the prog-
nostic value of CAVI in HD patients remains totally unclear. Hence, fur-
ther clinical study is essential to elucidate the clinical signiﬁcance of
CAVI in HD patient.
The present study has several limitations. First, this study was per-
formed in a single-center and the number of patients is relatively
small. Second, the present study was aimed at patients with ESRD, all
of whom take a variety of cardiovascular agents. Various values estimat-
ed in this study could be have been inﬂuenced by these medications.
Despite these limitations, we clearly and ﬁrstly demonstrated the
close association between newvascular indices and conventional BP pa-
rameters, indicating clinical usefulness of AVI andAPImeasurements for
risk stratiﬁcation of ESRD patients on HD.dio-ankle vascular index. Abbreviations used are the same as in Fig. 1.
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